Journal article · 2008
Preclinicalversusclinical drug combination studies
Leukemia & lymphoma/Leukemia and lymphoma, 49(11), 2059–2080 · Published 1 January 2008 · DOI 10.1080/10428190802353591
In brief
“Preclinicalversusclinical drug combination studies” is a 2008 journal article by Ting‐Chao Chou, published in Leukemia & lymphoma/Leukemia and lymphoma. OpenAlex counts 315 citations as of 15 November 2026, which puts it in the top 1% of works published in 2008 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 315
- Most cited in
- 2021 (32)
- Field-weighted impact
- 3.69
- References
- 18
- Authors
- 1
Abstract
This brief review provides a practical guide for drug combination studies and delineates its essence in terms of the mass-action-based theory, experimental design and automated computerised data analysis. The combination index (CI) method of Chou-Talalay is based on the multiple drug effect equation derived from the median-effect principle of the mass-action law. It provides quantitative… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Chou, T. (2008). Preclinicalversusclinical drug combination studies. Leukemia & lymphoma/Leukemia and lymphoma, 49(11), 2059–2080. https://doi.org/10.1080/10428190802353591
MLA 9
Chou, Ting‐Chao. “Preclinicalversusclinical drug combination studies.” Leukemia & lymphoma/Leukemia and lymphoma, vol. 49, no. 11, 2008, pp. 2059–2080. https://doi.org/10.1080/10428190802353591.
Chicago
Chou, Ting‐Chao. 2008. “Preclinicalversusclinical drug combination studies.” Leukemia & lymphoma/Leukemia and lymphoma 49 (11): 2059–2080. https://doi.org/10.1080/10428190802353591.
Harvard
Chou, T. (2008) ‘Preclinicalversusclinical drug combination studies’, Leukemia & lymphoma/Leukemia and lymphoma, 49(11), pp. 2059–2080. doi:10.1080/10428190802353591.
IEEE
T. Chou, “Preclinicalversusclinical drug combination studies,” Leukemia & lymphoma/Leukemia and lymphoma, vol. 49, no. 11, pp. 2059–2080, 2008, doi: 10.1080/10428190802353591.
BibTeX
@article{chou2008preclinicalversusclinical,
title = {{Preclinicalversusclinical drug combination studies}},
author = {Chou, Ting‐Chao},
journal = {Leukemia \& lymphoma/Leukemia and lymphoma},
year = {2008},
volume = {49},
number = {11},
pages = {2059--2080},
doi = {10.1080/10428190802353591},
url = {https://doi.org/10.1080/10428190802353591}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 11 | |
| 2018 | 17 | |
| 2019 | 20 | |
| 2020 | 22 | |
| 2021 | 32 | |
| 2022 | 17 | |
| 2023 | 22 | |
| 2024 | 31 | |
| 2025 | 31 | |
| 2026 | 10 |
Its field-weighted citation impact is 3.69: it has been cited 3.69 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- combination index
- Chou-Talalay method
- mass action law
- drug synergy
- drug antagonism
- additive drug effects
- isobologram
- dose reduction index
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Chou, T. (2008). Preclinicalversusclinical drug combination studies. Leukemia & lymphoma/Leukemia and lymphoma, 49(11), 2059–2080. https://doi.org/10.1080/10428190802353591
How many times has this paper been cited?
315 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Ting‐Chao Chou.
What is the DOI of this paper?
10.1080/10428190802353591. The permanent link is https://doi.org/10.1080/10428190802353591.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.